论文部分内容阅读
目的:探讨抗感染方结合西药治疗慢性阻塞性肺疾病的临床治疗价值。方法:选取2011年~2013年以来我院慢性阻塞性肺疾病患者80例,随机分为对照组32例和治疗组48例。对照组根据临床症状及痰培养、药敏试验合理使用抗生素、支气管扩张剂,严重者使用糖皮质激素、利尿剂,低流量给氧,雾化吸入及支持对症治疗。治疗组在对照组的基础上加用抗感染方治疗。两周为一个疗程,一疗程结束,对比两组患者的临床疗效。结果:治疗后总有效率(临床控制+显效)比较,治疗组为91.7%,对照组为69%(P<0.01)。结论:抗感染方结合西药治疗慢性阻塞性肺疾病优于单用西医治疗,不良反应少。
Objective: To explore the clinical value of anti-infection combined with western medicine in the treatment of chronic obstructive pulmonary disease. Methods: Eighty patients with chronic obstructive pulmonary disease in our hospital from 2011 to 2013 were randomly divided into control group (32 cases) and treatment group (48 cases). In the control group, antibiotics and bronchodilators were used reasonably according to the clinical symptoms and sputum culture. Drugs such as glucocorticoids, diuretics, low-flow oxygen, inhalation and supportive symptomatic treatment were used. Treatment group in the control group based on the addition of anti-infective side treatment. Two weeks for a course of treatment, a course of treatment, compared the clinical efficacy of two groups of patients. Results: The total effective rate (clinical control + effective) after treatment was 91.7% in the treatment group and 69% in the control group (P <0.01). Conclusion: The combination of anti-infective side and western medicine is superior to Western medicine alone in treatment of chronic obstructive pulmonary disease with less adverse reactions.